BVS Dividend: Bioventus Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

BVS Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	563	573	512	512	430	321
Revenue Growth (YoY)	1%	12%	0%	19%	34%	-6%
Cost of Revenue	181	185	184	181	128	87
Gross Profit	382	388	328	331	302	233
Selling, General & Admin	317	340	303	332	254	187
Research & Development	12	13	13	25	19	11
Operating Expenses	336	363	326	386	282	206
Other Non Operating Income (Expenses)	-2	0	0	11	-4	0
Pretax Income	11	-49	-121	-263	7	15
Income Tax Expense	2	-5	0	-50	-2	1
Net Income	7	-33	-156	-158	19	4
Net Income Growth	-118%	-79%	-1%	-932%	375%	--
Shares Outstanding (Diluted)	68.83	64.54	62.64	61.4	45.5	55.6
Shares Change (YoY)	5%	3%	2%	35%	-18%	0%
EPS (Diluted)	0.11	-0.51	-2.49	-2.59	0.43	0.08
EPS Growth	-118%	-79%	-4%	-702%	438%	-900%
Free Cash Flow	53	37	7	-23	15	67
Free Cash Flow Per Share	0.76	0.57	0.11	-0.37	0.32	1.2
Gross Margin	67.85%	67.71%	64.06%	64.64%	70.23%	72.58%
Operating Margin	7.99%	4.18%	0.19%	-10.74%	4.65%	8.41%
Profit Margin	1.24%	-5.75%	-30.46%	-30.85%	4.41%	1.24%
Free Cash Flow Margin	9.41%	6.45%	1.36%	-4.49%	3.48%	20.87%
EBITDA	51	31	9	-34	28	34
EBITDA Margin	9.05%	5.41%	1.75%	-6.64%	6.51%	10.59%
D&A For EBITDA	6	7	8	21	8	7
EBIT	45	24	1	-55	20	27
EBIT Margin	7.99%	4.18%	0.19%	-10.74%	4.65%	8.41%
Effective Tax Rate	18.18%	10.2%	0%	19.01%	-28.57%	6.66%